Billiontoone To Participate In The Piper Sandler 38Th Annual Healthcare Conference


Date:

(MENAFN- GlobeNewsWire - Nasdaq) MENLO PARK, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the Piper Sandler 38th Annual Healthcare Conference.

Management will participate in a fireside chat from 3:00pm to 3:25pm Eastern Time on Tuesday, December 1, 2026.

A live and archived webcast will be available on the“Events & Presentations” page of BillionToOne's investor relations website at .

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting TemplatesTM (QCTTM) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit .

Investor Contact
...

Media Contact
...


MENAFN18112026004107003653ID1111982874


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search